Cell BiologybioRxivPreprint
Nilotinib activates endothelial TLR4 to exacerbate atherosclerosis
D. Qu, M. Huo, L. Wang…·Y. Huang
This study shows nilotinib activates endothelial TLR4, promoting atherosclerosis, and suggests TLR4 inhibition could mitigate this effect.
DOI 10.1101/2019.12.14.876599